Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria

Polymyxins are polycationic antimicrobial peptides that are currently the last-resort antibiotics for the treatment of multidrug-resistant, Gram-negative bacterial infections. The reintroduction of polymyxins for antimicrobial therapy has been followed by an increase in reports of resistance among Gram-negative bacteria. Some bacteria, such as Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii, develop resistance to polymyxins in a process referred to as acquired resistance, whereas other bacteria, such as Proteus spp., Serratia spp., and Burkholderia spp., are naturally resistant to these drugs. Reports of polymyxin resistance in clinical isolates have recently increased, including acquired and intrinsically resistant pathogens. This increase is considered a serious issue, prompting concern due to the low number of currently available effective antibiotics. This review summarizes current knowledge concerning the different strategies bacteria employ to resist the activities of polymyxins. Gram-negative bacteria employ several strategies to protect themselves from polymyxin antibiotics (polymyxin B and colistin), including a variety of lipopolysaccharide (LPS) modifications, such as modifications of lipid A with phosphoethanolamine and 4-amino-4-deoxy-L-arabinose, in addition to the use of efflux pumps, the formation of capsules and overexpression of the outer membrane protein OprH, which are all effectively regulated at the molecular level. The increased understanding of these mechanisms is extremely vital and timely to facilitate studies of antimicrobial peptides and find new potential drugs targeting clinically relevant Gram-negative bacteria.

Saved in:
Bibliographic Details
Main Authors: Olaitan, Abiola Olumuyiwa, Morand, Serge, Rolain, Jean-Marc
Format: article biblioteca
Language:eng
Subjects:L73 - Maladies des animaux, Bacteria, bactérie gram négatif, Résistance aux antibiotiques, polymyxine, lipopolysaccharide, Enterobacteriaceae, Bacillus, mutation, http://aims.fao.org/aos/agrovoc/c_765, http://aims.fao.org/aos/agrovoc/c_3352, http://aims.fao.org/aos/agrovoc/c_8848, http://aims.fao.org/aos/agrovoc/c_29694, http://aims.fao.org/aos/agrovoc/c_24045, http://aims.fao.org/aos/agrovoc/c_2580, http://aims.fao.org/aos/agrovoc/c_760, http://aims.fao.org/aos/agrovoc/c_5014,
Online Access:http://agritrop.cirad.fr/578563/
http://agritrop.cirad.fr/578563/1/fmicb-05-00643.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
id dig-cirad-fr-578563
record_format koha
spelling dig-cirad-fr-5785632024-01-28T23:06:37Z http://agritrop.cirad.fr/578563/ http://agritrop.cirad.fr/578563/ Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria. Olaitan Abiola Olumuyiwa, Morand Serge, Rolain Jean-Marc. 2014. Frontiers in Microbiology, 5 (643), 18 p.https://doi.org/10.3389/fmicb.2014.00643 <https://doi.org/10.3389/fmicb.2014.00643> Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria Olaitan, Abiola Olumuyiwa Morand, Serge Rolain, Jean-Marc eng 2014 Frontiers in Microbiology L73 - Maladies des animaux Bacteria bactérie gram négatif Résistance aux antibiotiques polymyxine lipopolysaccharide Enterobacteriaceae Bacillus mutation http://aims.fao.org/aos/agrovoc/c_765 http://aims.fao.org/aos/agrovoc/c_3352 http://aims.fao.org/aos/agrovoc/c_8848 http://aims.fao.org/aos/agrovoc/c_29694 http://aims.fao.org/aos/agrovoc/c_24045 http://aims.fao.org/aos/agrovoc/c_2580 http://aims.fao.org/aos/agrovoc/c_760 http://aims.fao.org/aos/agrovoc/c_5014 Polymyxins are polycationic antimicrobial peptides that are currently the last-resort antibiotics for the treatment of multidrug-resistant, Gram-negative bacterial infections. The reintroduction of polymyxins for antimicrobial therapy has been followed by an increase in reports of resistance among Gram-negative bacteria. Some bacteria, such as Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii, develop resistance to polymyxins in a process referred to as acquired resistance, whereas other bacteria, such as Proteus spp., Serratia spp., and Burkholderia spp., are naturally resistant to these drugs. Reports of polymyxin resistance in clinical isolates have recently increased, including acquired and intrinsically resistant pathogens. This increase is considered a serious issue, prompting concern due to the low number of currently available effective antibiotics. This review summarizes current knowledge concerning the different strategies bacteria employ to resist the activities of polymyxins. Gram-negative bacteria employ several strategies to protect themselves from polymyxin antibiotics (polymyxin B and colistin), including a variety of lipopolysaccharide (LPS) modifications, such as modifications of lipid A with phosphoethanolamine and 4-amino-4-deoxy-L-arabinose, in addition to the use of efflux pumps, the formation of capsules and overexpression of the outer membrane protein OprH, which are all effectively regulated at the molecular level. The increased understanding of these mechanisms is extremely vital and timely to facilitate studies of antimicrobial peptides and find new potential drugs targeting clinically relevant Gram-negative bacteria. article info:eu-repo/semantics/article Journal Article info:eu-repo/semantics/publishedVersion http://agritrop.cirad.fr/578563/1/fmicb-05-00643.pdf text cc_by info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by/4.0/ https://doi.org/10.3389/fmicb.2014.00643 10.3389/fmicb.2014.00643 info:eu-repo/semantics/altIdentifier/doi/10.3389/fmicb.2014.00643 info:eu-repo/semantics/altIdentifier/purl/https://doi.org/10.3389/fmicb.2014.00643
institution CIRAD FR
collection DSpace
country Francia
countrycode FR
component Bibliográfico
access En linea
databasecode dig-cirad-fr
tag biblioteca
region Europa del Oeste
libraryname Biblioteca del CIRAD Francia
language eng
topic L73 - Maladies des animaux
Bacteria
bactérie gram négatif
Résistance aux antibiotiques
polymyxine
lipopolysaccharide
Enterobacteriaceae
Bacillus
mutation
http://aims.fao.org/aos/agrovoc/c_765
http://aims.fao.org/aos/agrovoc/c_3352
http://aims.fao.org/aos/agrovoc/c_8848
http://aims.fao.org/aos/agrovoc/c_29694
http://aims.fao.org/aos/agrovoc/c_24045
http://aims.fao.org/aos/agrovoc/c_2580
http://aims.fao.org/aos/agrovoc/c_760
http://aims.fao.org/aos/agrovoc/c_5014
L73 - Maladies des animaux
Bacteria
bactérie gram négatif
Résistance aux antibiotiques
polymyxine
lipopolysaccharide
Enterobacteriaceae
Bacillus
mutation
http://aims.fao.org/aos/agrovoc/c_765
http://aims.fao.org/aos/agrovoc/c_3352
http://aims.fao.org/aos/agrovoc/c_8848
http://aims.fao.org/aos/agrovoc/c_29694
http://aims.fao.org/aos/agrovoc/c_24045
http://aims.fao.org/aos/agrovoc/c_2580
http://aims.fao.org/aos/agrovoc/c_760
http://aims.fao.org/aos/agrovoc/c_5014
spellingShingle L73 - Maladies des animaux
Bacteria
bactérie gram négatif
Résistance aux antibiotiques
polymyxine
lipopolysaccharide
Enterobacteriaceae
Bacillus
mutation
http://aims.fao.org/aos/agrovoc/c_765
http://aims.fao.org/aos/agrovoc/c_3352
http://aims.fao.org/aos/agrovoc/c_8848
http://aims.fao.org/aos/agrovoc/c_29694
http://aims.fao.org/aos/agrovoc/c_24045
http://aims.fao.org/aos/agrovoc/c_2580
http://aims.fao.org/aos/agrovoc/c_760
http://aims.fao.org/aos/agrovoc/c_5014
L73 - Maladies des animaux
Bacteria
bactérie gram négatif
Résistance aux antibiotiques
polymyxine
lipopolysaccharide
Enterobacteriaceae
Bacillus
mutation
http://aims.fao.org/aos/agrovoc/c_765
http://aims.fao.org/aos/agrovoc/c_3352
http://aims.fao.org/aos/agrovoc/c_8848
http://aims.fao.org/aos/agrovoc/c_29694
http://aims.fao.org/aos/agrovoc/c_24045
http://aims.fao.org/aos/agrovoc/c_2580
http://aims.fao.org/aos/agrovoc/c_760
http://aims.fao.org/aos/agrovoc/c_5014
Olaitan, Abiola Olumuyiwa
Morand, Serge
Rolain, Jean-Marc
Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria
description Polymyxins are polycationic antimicrobial peptides that are currently the last-resort antibiotics for the treatment of multidrug-resistant, Gram-negative bacterial infections. The reintroduction of polymyxins for antimicrobial therapy has been followed by an increase in reports of resistance among Gram-negative bacteria. Some bacteria, such as Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii, develop resistance to polymyxins in a process referred to as acquired resistance, whereas other bacteria, such as Proteus spp., Serratia spp., and Burkholderia spp., are naturally resistant to these drugs. Reports of polymyxin resistance in clinical isolates have recently increased, including acquired and intrinsically resistant pathogens. This increase is considered a serious issue, prompting concern due to the low number of currently available effective antibiotics. This review summarizes current knowledge concerning the different strategies bacteria employ to resist the activities of polymyxins. Gram-negative bacteria employ several strategies to protect themselves from polymyxin antibiotics (polymyxin B and colistin), including a variety of lipopolysaccharide (LPS) modifications, such as modifications of lipid A with phosphoethanolamine and 4-amino-4-deoxy-L-arabinose, in addition to the use of efflux pumps, the formation of capsules and overexpression of the outer membrane protein OprH, which are all effectively regulated at the molecular level. The increased understanding of these mechanisms is extremely vital and timely to facilitate studies of antimicrobial peptides and find new potential drugs targeting clinically relevant Gram-negative bacteria.
format article
topic_facet L73 - Maladies des animaux
Bacteria
bactérie gram négatif
Résistance aux antibiotiques
polymyxine
lipopolysaccharide
Enterobacteriaceae
Bacillus
mutation
http://aims.fao.org/aos/agrovoc/c_765
http://aims.fao.org/aos/agrovoc/c_3352
http://aims.fao.org/aos/agrovoc/c_8848
http://aims.fao.org/aos/agrovoc/c_29694
http://aims.fao.org/aos/agrovoc/c_24045
http://aims.fao.org/aos/agrovoc/c_2580
http://aims.fao.org/aos/agrovoc/c_760
http://aims.fao.org/aos/agrovoc/c_5014
author Olaitan, Abiola Olumuyiwa
Morand, Serge
Rolain, Jean-Marc
author_facet Olaitan, Abiola Olumuyiwa
Morand, Serge
Rolain, Jean-Marc
author_sort Olaitan, Abiola Olumuyiwa
title Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria
title_short Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria
title_full Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria
title_fullStr Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria
title_full_unstemmed Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria
title_sort mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria
url http://agritrop.cirad.fr/578563/
http://agritrop.cirad.fr/578563/1/fmicb-05-00643.pdf
work_keys_str_mv AT olaitanabiolaolumuyiwa mechanismsofpolymyxinresistanceacquiredandintrinsicresistanceinbacteria
AT morandserge mechanismsofpolymyxinresistanceacquiredandintrinsicresistanceinbacteria
AT rolainjeanmarc mechanismsofpolymyxinresistanceacquiredandintrinsicresistanceinbacteria
_version_ 1792498944569245696